• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by IM Cannabis Corp.

    3/5/25 7:03:32 AM ET
    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $IMCC alert in real time by email
    6-K 1 zk2532801.htm 6-K


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 6-K

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934
     
    For the month of February 2025.
     
    Commission File Number: 001-40065

    IM Cannabis Corp.
    (Exact Name of Registrant as Specified in Charter)

    Kibbutz Glil Yam, Central District, Israel 4690500
    (Address of principal executive offices)
     
    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

    Form 20-F ☒  Form 40-F ☐
     
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
     
    Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
     
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
     
    Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
     

    SIGNATURE
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
     
     
     
    IM CANNABIS CORP.
     
     
    (Registrant)
     
     
     
     
    Date:
    March 5, 2025
    By:
    /s/ Oren Shuster
     
     
    Name:
    Oren Shuster
     
     
    Title:
    Chief Executive Officer and Director
     

    EXHIBIT INDEX
     
    99.1
    Form 7 - Monthly Progress Report dated March 5, 2025


    Get the next $IMCC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IMCC

    DatePrice TargetRatingAnalyst
    10/5/2021$8.00Buy
    ROTH Capital
    7/14/2021Buy
    Desjardins
    7/14/2021$10.50Buy
    Desjardins
    More analyst ratings

    $IMCC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction

      TORONTO and GLIL YAM, Israel, May 7, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further its news release dated April 11, 2025 (the "April 11 Release"), it has filed a management information circular (the "Circular") in connection with the upcoming annual general and special meeting of the shareholders of the Company ("Shareholders") to be held on May 23, 2025 (the "Meeting"). Capitalized terms not otherwise defined herein have the meanings attributed to them in the April 11 Release.     Meeting Details The Company's board of directors

      5/7/25 7:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET

      TORONTO and GLIL YAM, Israel, May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens.     The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration. If you are unable to join us live, a recording of the

      5/6/25 7:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Provides Corporate Updates

      TORONTO and GLIL YAM, Israel, April 11, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced the following corporate updates.     Nasdaq Notification Letter The Company has received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") dated April 9, 2025, notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1). Nasdaq Listing Rule 5550(b)(1) (the "Listing Rule") requires companies listed on the Nasdaq Capital Market to maintain a minimum of US$2.5 million in stockholders'

      4/11/25 7:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH Capital initiated coverage on IM Cannabis with a new price target

      ROTH Capital initiated coverage of IM Cannabis with a rating of Buy and set a new price target of $8.00

      10/5/21 7:57:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Desjardins initiated coverage on IMC Mortgage Co

      Desjardins initiated coverage of IMC Mortgage Co with a rating of Buy

      7/14/21 8:40:32 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Desjardins initiated coverage on IM Cannabis with a new price target

      Desjardins initiated coverage of IM Cannabis with a rating of Buy and set a new price target of $10.50

      7/14/21 7:01:53 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by IM Cannabis Corp.

      SC 13G - IM Cannabis Corp. (0001792030) (Subject)

      2/21/23 10:56:41 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by IM Cannabis Corp. (Amendment)

      SC 13D/A - IM Cannabis Corp. (0001792030) (Subject)

      2/8/23 1:29:15 PM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by IM Cannabis Corp. (Amendment)

      SC 13G/A - IM Cannabis Corp. (0001792030) (Subject)

      2/2/23 10:38:01 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    SEC Filings

    See more
    • SEC Form 6-K filed by IM Cannabis Corp.

      6-K - IM Cannabis Corp. (0001792030) (Filer)

      5/7/25 7:17:55 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by IM Cannabis Corp.

      6-K - IM Cannabis Corp. (0001792030) (Filer)

      5/6/25 7:28:10 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by IM Cannabis Corp.

      6-K - IM Cannabis Corp. (0001792030) (Filer)

      5/5/25 7:19:52 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    Leadership Updates

    Live Leadership Updates

    See more
    • IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

      TORONTO and GLIL YAM, Israel, Sept. 11, 2024 /PRNewswire/ --  IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company's board of directors (the "Board") effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company's commitment to driving growth while focusing on sustainable profitability. "We are thrilled to welcome Shmulik to our Board of Directors," said Oren Shuster, Chief Executive Officer of

      9/11/24 8:30:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer

      TORONTO and GLIL YAM, Israel, Oct. 10, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Uri Birenberg will join the company's leadership team as Chief Financial Officer effective October 10, 2023.  This appointment strengthens IMC's financial leadership and strategic direction for achieving sustainable profitability. "We're delighted to welcome Uri as our new Chief Financial Officer at IMC. His impressive track record and extensive experience with large scale international organizations, as well as with startups, make him an outstandin

      10/10/23 7:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company's Israeli Subsidiary

      Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp.TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 13, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany today announced the appointment of Rinat Efrima as the new Chief Executive Officer of IMC Holdings Ltd. ("IMC Holdings"), the Company's wholly-owned Israeli subsidiary. Ms. Efrima will join the Company in the first quarter of 2022. In addition, Ya

      1/13/22 8:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care

    $IMCC
    Financials

    Live finance-specific insights

    See more
    • IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET

      TORONTO and GLIL YAM, Israel, May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens.     The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration. If you are unable to join us live, a recording of the

      5/6/25 7:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

      Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel, March 31, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise stated, all amounts are reported in Canadian dollars and are compared to the quarter ended December 31, 2023. The Company's audited consolidated financial statements for the fiscal years ended December 31, 2024 and 2023 and accompanying manage

      3/31/25 8:39:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care
    • IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

      TORONTO and GLIL YAM, Israel, March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens. The Company will host a zoom web conference on the same day at 9:00a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration. If you are unable to join us live, a

      3/20/25 7:00:00 AM ET
      $IMCC
      Medicinal Chemicals and Botanical Products
      Health Care